Overactive Bladder--Pharmacological Aspects-Reference-Cited by-同舟云学术

Overactive Bladder--Pharmacological Aspects

Published:2002-01-01 Issue:4 Volume:36 Page:72-81
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Andersson K.-E.¹

Affiliation:

1. Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/003655902320766006

Reference111 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society

2. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

3. Andersson K-E, Appell R, Awad S, Chapple C, Drutz H, Fourcroy J, et al. Pharmacological treatment of urinary incontinence. In: Abrams P, Khoury S, Wein A, eds. Incontinence, 2nd International Consultation on Incontinence. UK: Plymbridge Distributors Ltd; 2002: pp. 479–511.

4. Bumstock G. Purinergic signalling in lower urinary tract. In: Handbook of Experimental Pharmacology, Vol 15 1/I. Purinergic and Pyrimidinergic Signalling I Molecular, Nervous and Urogenitary System Function. Abbracchio MP and Williams M, eds. Berlin, Heidel-berg: Springer-Verlag; 2001. pp. 423–515.

5. Bladder activation: afferent mechanisms

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients;Biomedicines;2023-04-17

2. The five primary prostaglandins stimulate contractions and phasic activity of the urinary bladder urothelium, lamina propria and detrusor;BMC Urology;2020-04-29

3. Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spianl Cord Injury;International Neurourology Journal;2017-09-30

4. Current evidence and emerging drug therapies for overactive bladder;Minerva Obstetrics and Gynecology;2017-04

5. Current and future pharmacotherapy for treating overactive bladder;Expert Opinion on Pharmacotherapy;2016-06-02